Epicrispr Biotechnologies Lands $8M Grant
Epicrispr Biotechnologies has received an $8 million grant, FinSMEs reports. The non-dilutive award adds capital to the epigenomic editing firm without new equity terms.
Topic
Epicrispr
Topic
Topic
Topic
Epicrispr Biotechnologies has received an $8 million grant, FinSMEs reports. The non-dilutive award adds capital to the epigenomic editing firm without new equity terms.